A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres (English)
- New search for: Blanchette, V. S.
- New search for: Mccready, M.
- New search for: Achonu, C.
- New search for: Abdolell, M.
- New search for: Rivard, G.
- New search for: Manco‐Johnson, M. J.
- New search for: Blanchette, V. S.
- New search for: Mccready, M.
- New search for: Achonu, C.
- New search for: Abdolell, M.
- New search for: Rivard, G.
- New search for: Manco‐Johnson, M. J.
In:
Haemophilia
;
9
;
19-26
;
2003
- Article (Journal) / Electronic Resource
-
Title:A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres
-
Contributors:Blanchette, V. S. ( author ) / Mccready, M. ( author ) / Achonu, C. ( author ) / Abdolell, M. ( author ) / Rivard, G. ( author ) / Manco‐Johnson, M. J. ( author )
-
Published in:Haemophilia ; 9 ; 19-26
-
Publisher:
- New search for: Blackwell Publishing Ltd
-
Publication date:2003-05-01
-
Size:8 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 9
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Consensus perspectives on prophylactic therapy for haemophilia: summary statementBerntorp, E. / Astermark, J. / Björkman, S. / Blanchette, V. S. / Fischer, K. / Giangrande, P. L. F. / Gringeri, A. / Ljung, R. C. / Manco‐Johnson, M. J. / Morfini, M. et al. | 2003
- 1
-
Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disordersUnited Kingdom Haemophilia Centre Doctors’ Organisation (UKHCDO) et al. | 2003
- 5
-
Prophylactic therapy for haemophilia: early experienceBerntorp, E. et al. | 2003
- 10
-
A global view on prophylaxis: possibilities and consequencesShapiro, A. D. et al. | 2003
- 19
-
A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centresBlanchette, V. S. / Mccready, M. / Achonu, C. / Abdolell, M. / Rivard, G. / Manco‐Johnson, M. J. et al. | 2003
- 24
-
Nanofiltration of plasma‐derived biopharmaceutical productsBurnouf, T. / Radosevich, M. et al. | 2003
- 27
-
Comparing outcomes of different treatment regimens for severe haemophiliaVan Den Berg, H. M. / Fischer, K. / Van Der Bom, J. G. et al. | 2003
- 32
-
When to start and when to stop primary prophylaxis in patients with severe haemophiliaAstermark, J. et al. | 2003
- 38
-
The safety and efficacy of B‐domain deleted recombinant factor VIII concentrate in patients with severe haemophilia ALusher, J. M. / Lee, C. A. / Kessler, C. M. / Bedrosian, C. L. / for the ReFacto Phase 3 Study Group et al. | 2003
- 38
-
Prospective controlled studies on prophylaxis: an Italian approachGringeri, A. et al. | 2003
- 44
-
North American prophylaxis studies for persons with severe haemophilia: background, rationale and designManco‐Johnson, M. J. / Blanchette, V. S. et al. | 2003
- 50
-
Adverse events in the prophylaxis of haemophiliaGiangrande, P. L. F. et al. | 2003
- 50
-
Complications of central venous access devices in paediatric haemophilia patientsDomm, J. A. / Hudson, M. G. / Janco, R. L. et al. | 2003
- 57
-
An evaluation of the stability of factor VIII inhibitors in plasma and plasma dried on filter paper discs stored at room temperatureWinikoff, R. / Boulanger, A. / St Louis, J. / Lacroix, S. / Rivard, G.‐É. et al. | 2003
- 57
-
Radiological assessment of haemophilic arthropathy with emphasis on MRI findingsKilcoyne, R. F. / Nuss, R. et al. | 2003
- 60
-
Intra‐articular rifamycin in haemophilic arthropathyRadossi, P. / Baggio, R. / Petris, U. / Biasi, E. De / Risato, R. / Davoli, P. G. / Tagariello, G. et al. | 2003
- 64
-
Treatment of chronic haemophilic synovitis in humans with D‐penicillamineCorrigan, J. J. Jr / Damiano, M. L. / Leissinger, C. / Wulff, K. et al. | 2003
- 65
-
Orthopaedic assessment in haemophiliaRodriguez‐Merchan, E. C. et al. | 2003
- 69
-
Long‐term follow‐up after osteotomy for haemophilic arthropathy of the kneeWallny, T. / Saker, A. / Hofmann, P. / Brackmann, H. H. / Nicolay, C. / Kraft, C. N. et al. | 2003
- 75
-
Health‐related quality of life as outcome parameter in haemophilia treatmentFischer, K. / Van Der Bom, J. G. / Van Den Berg, H. M. et al. | 2003
- 76
-
Value of magnetic resonance imaging for the diagnosis and follow‐up of haemophilic arthropathyDobón, M. / Lucía, J. F. / Aguilar, C. / Mayayo, E. / Roca, M. / Solano, V. / Peña, A. / Giralt, M. / Ferrández, A. et al. | 2003
- 83
-
How to start prophylaxisPetrini, P. et al. | 2003
- 86
-
Physical training increases isometric muscular strength and proprioceptive performance in haemophilic subjectsHilberg, T. / Herbsleb, M. / Puta, C. / Gabriel, H. H. W. / Schramm, W. et al. | 2003
- 88
-
Central venous lines in haemophiliaLjung, R. et al. | 2003
- 94
-
Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long‐terminal repeatsVan Damme, A. / Chuah, M. K. L. / Dell'accio, F. / De Bari, C. / Luyten, F. / Collen, D. / VandenDriessche, T. et al. | 2003
- 94
-
Pharmacokinetics of factor VIII and factor IXMorfini, M. et al. | 2003
- 101
-
Prophylactic dosing of factor VIII and factor IX from a clinical pharmacokinetic perspectiveBjörkman, S. et al. | 2003
- 104
-
Optimization of storage conditions for diluted working solutions of porcine factor VIII and performance of the Bethesda assay for the determination of antiporcine FVIII inhibitor titresWinikoff, R. / Boulanger, A. / Robinson, P. / ST‐Louis, J. / Lacroix, S. / Rivard, G.‐É. et al. | 2003
- 110
-
Hepatitis G virus in clotting factor concentratesAlonso‐Rubiano, E. / Gerber, M. / Friedman, P. / Hodges, S. / Leissinger, C. et al. | 2003
- 111
-
Economics of prophylactic treatmentSchramm, W. / Berger, K. et al. | 2003
- 116
-
Carrier testing and prenatal diagnosis of haemophilia B by SSCP in an Iranian familyKarimipoor, M. / Zeinali, S. / Lak, M. / Safaee, R. et al. | 2003
- 117
-
CME Assessment Test and Evaluation Form| 2003
- 119
-
A case of an inhibitor autoantibody to coagulation factor VIIAguilar, C. / Lucía, J. F. / Hernández, P. et al. | 2003
- 121
-
Surgery in severe factor XIII deficiency: report of a case of epilepsy neurosurgery and reviewPernod, G. / Barro, C. / Arnutti, B. / Blanc‐Jouvan, F. / Garrel, S. / Kahn, P. / Minotti, L. / Koudsie, A. / Benabid, A. L. / Wrobleski, I. et al. | 2003
- 125
-
Female haemophiliac homozygous for the factor VIII intron 22 inversion mutation, with transcriptional inactivation of one of the factor VIII allelesDavid, D. / Morais, S. / Ventura, C. / Campos, M. et al. | 2003
- 131
-
Efficacy of NovoSeven® during surgery on a haemophiliac with previous history of inhibitorsSaba, H. I. / Morelli, G. A. / Azam, R. R. / Klein, C. J. / Letson, G. D. et al. | 2003
- 137
-
Type 2B vWD: the varied clinical manifestations in two kindredsMathew, P. / Greist, A. / Maahs, J. A. / Lichtenberg, E. C. / Shapiro, A. D. et al. | 2003
- 145
-
Gene therapy ethics and haemophilia: an inevitable therapeutic future?Dimichele, D. / Miller, F. G. / Fins, J. J. et al. | 2003
- 153
-
Historical and political implications of haemophilia in the Spanish royal familyOjeda‐Thies, C. / Rodriguez‐Merchan, E. C. et al. | 2003
- 157
-
In vivo recovery and safety of human factor VIII product AAFACT® in patients with haemophilia AVossebeld, P. J. M. / Tissing, M. H. / Van Den Berg, H. M. / Leebeek, F. W. G. / De Goede‐Bolder, A. / NovÁkovÁ, I. R. O. / Gerrits, W. B. J. / Peters, M. / Koopman, M. M. W. / Faber, A. et al. | 2003
- 164
-
Continuous intravenous infusion of a plasma‐derived factor IX concentrate (Mononine®) in haemophilia BHoots, W. K. / Leissinger, C. / Stabler, S. / Schwartz, B. A. / White, G. / Dasani, H. / Massion, C. / Negrier, C. / Schindel, F. / Schulman, S. et al. | 2003
- 173
-
Experience with a new percutaneous port system, Percuseal®, for intravenous injection in patients with haemophilia, von Willebrand disease and severe alpha1‐antitrypsin deficiencyBerntorp, E. / Piitulainen, E. / Lethagen, S. / Mattson, E. / Tengborn, L. / Mätzsch, T. et al. | 2003
- 179
-
Genotype and phenotype of haemophilia A in Thai patientsYenchitsomanus, P. / Akkarapatumwong, V. / Pung‐Amritt, P. / Intorasoot, S. / Thanootarakul, P. / Oranwiroon, S. / Veerakul, G. / Mahasandana, C. et al. | 2003
- 187
-
Analysis of haemophilia B database and strategies for identification of common point mutations in the factor IX geneMukherjee, S. / Mukhopadhyay, A. / Chaudhuri, K. / Ray, K. et al. | 2003
- 193
-
Inherited bleeding disorders in Indian women with menorrhagiaSaxena, R. / Gupta, M. / Gupta, P. K. / Kashyap, R. / Choudhry, V. P. / Bhargava, M. et al. | 2003
- 197
-
Haemophilic arthropathy of the hip in children – prognosis and long‐term follow‐upWallny, T. / Brackmann, H. H. / Seuser, A. / Diedrich, O. / Kraft, C. N. et al. | 2003
- 202
-
Analgesic use and pain coping among patients with haemophiliaElander, J. / Barry, T. et al. | 2003
- 214
-
Promoting safer sex among HIV‐positive youth with haemophilia: theory, intervention, and outcomeButler, R. B. / Schultz, J. R. / Forsberg, A. D. / Brown, L. K. / Parsons, J. T. / King, G. / Kocik, S. M. / Jarvis, D. / Schulz, S. L. / Manco‐Johnson, M. et al. | 2003
- 223
-
Third and Fourth Workshops of the European paediatric network for haemophilia management1Hill, F. G. H. / Ljung, R. et al. | 2003
- 229
-
Severe spontaneous intracranial haematoma in a HIV‐negative 66‐year‐old mild haemophiliac. Complete recovery with the use of 1‐month factor VIII replacementBauduer, F. / Delpy, P. / Borde, C. / Ducout, L. / Boutin, J. B. et al. | 2003
- 232
-
Hyponatraemic coma induced by desmopressin and ibuprofen in a woman with von Willebrand's diseaseGomez García, E. B. / Ruitenberg, A. / Madretsma, G. S. / Hintzen, R. Q. et al. | 2003
- 235
-
Misdiagnosis by milk boxLipton, Richard A. et al. | 2003
- 235
-
The clinical phenotype modulation of haemophilia by prothrombotic gene mutationsAraújo, F. / Fraga, M. / Henriques, I. / Monteiro, F. / Meireles, E. / Pereira, C. / Lacerda, P. / Cunha‐Ribeiro, L. M. et al. | 2003
- 237
-
Inhibitors in patients withhaemophilia| 2003
- 239
-
Editorial| 2003
- 240
-
The WFH Haemophilia Centre Twinning Programme: 10 years of growth, 1993–2003Giangrande, P. L. F. / Mariani, G. / Black, C. et al. | 2003
- 245
-
A country‐by‐country comparison of FVIII concentrate consumption and economic capacity for the global haemophilia communityStonebraker, J. S. / Amand, R. E. / Nagle, A. J. et al. | 2003
- 251
-
Comparative effectiveness of full‐length and B‐domain deleted factor VIII for prophylaxis – a meta‐analysisGruppo, R. A. / Brown, D. / Wilkes, M. M. / Navickis, R. J. et al. | 2003
- 261
-
Long‐term FEIBA prophylaxis does not prevent progression of existing joint diseaseHilgartner, M. W. / Makipernaa, A. / Dimichele, D. M. et al. | 2003
- 269
-
Management of haemophilia B inhibitor patients with anaphylactic reactions to FIX concentratesShibata, M. / Shima, M. / Misu, H. / Okimoto, Y. / Giddings, J. C. / Yoshioka, A. et al. | 2003
- 272
-
The overall effectiveness of prophylaxis in severe haemophiliaPanicker, J. / Warrier, I. / Thomas, R. / Lusher, J. M. et al. | 2003
- 279
-
Prophylaxis in factor IX deficiency product and patient variationKisker, C.T. / Eisberg, A. / Schwartz, B. / the Mononine Study Group et al. | 2003
- 285
-
Pilot study of an Internet‐based electronic patient treatment record and communication system for haemophilia, Advoy.comCollins, P. W. / Bolton‐Maggs, P. / Stephenson, D. / Jenkins, B. / Loran, C. / Winter, M. et al. | 2003
- 292
-
Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case–control studyKirtava, A. / Drews, C. / Lally, C. / Dilley, A. / Evatt, B. et al. | 2003
- 298
-
The role of the platelet function analyser (PFA‐100TM) in the characterization of patients with von Willebrand's disease and its relationships with von Willebrand factor and the ABO blood groupNitu‐Whalley, I. C. / Lee, C. A. / Brown, S. A. / Riddell, A. / Hermans, C. et al. | 2003
- 303
-
A new ELISA assay for diagnosis of acquired von Willebrand SyndromeSiaka, C. / Rugeri, L. / Caron, C. / Goudemand, J. et al. | 2003
- 309
-
Providing assisted reproductive care to male haemophiliacs infected with human immunodeficiency virus: preliminary experiencePeña, J. E. / Klein, J. / Thornton, M. H. II / Sauer, M. V. et al. | 2003
- 317
-
Social adjustment in three cultures: data from families affected by chronic blood disorders. A sibling studyClemente, C. / Tsiantis, J. / Kolvin, I. / Ba, G. / Christogiorgos, S. / Lee, C. / Taylor, B. / Miller, R. et al. | 2003
- 325
-
The Hemophilia Utilization Group Study (HUGS): determinants of costs of care in persons with haemophilia AGlobe, D. R. / Cunningham, W. E. / Andersen, R. / Dietrich, S. L. / Curtis, R. G. / Parish, K. L. / Miller, R. T. / Sanders, N. L. / Kominski, G. et al. | 2003
- 332
-
Painless urethral bleeding: an unusual presentation of Von Willebrand diseaseArmenian, S. / Raffel, J. L. / Nugent, D. J. / Young, G. et al. | 2003
- 336
-
The treatment of flexion contracture of the knee using the Ilizarov technique in a child with haemophilia BKiely, P. D. / McMahon, C. / Smith, O. P. / Moore, D. P. et al. | 2003
- 340
-
Successful induction of immune tolerance in a patient with haemophilia B with inhibitorSuzuki, N. / Watanabe, J. / Kudoh, T. / Hori, T. / Hatakeyama, N. / Mizue, N. / Oda, T. / Tsutsumi, H. et al. | 2003
- 343
-
Health outcome assessment: SF‐36 in English and SpanishRodriguez‐Merchan, E. C. et al. | 2003
- 346
-
Prize on congenital coagulations disorders| 2003
- 347
-
The delivery of treatment for haemophilia| 2003
- 348
-
Potential role of the dynamic properties of whole blood coagulation in assessment of dosage requirements in haemophiliaIngerslev, J. / Poulsen, L. H. / Sørensen, B. et al. | 2003
- 353
-
The pharmacokinetics of clotting factor therapyBerntorp, E. / Björkman, S. et al. | 2003
- 360
-
Treatment on demand –in vivo dose finding studiesEscobar, M. A. et al. | 2003
- 368
-
Continuous infusionSchulman, S. et al. | 2003
- 376
-
Prophylaxis for severe haemophilia: clinical and economical issuesFischer, K. / Berg Van den, M. et al. | 2003
- 382
-
Immune tolerance therapy dose as an outcome predictorDiMichele, Donna et al. | 2003
- 387
-
Treatment of haemophilia in the developing countriesChuansumrit, A. et al. | 2003
- 391
-
Factor replacement therapy in haemophilia – are there models for developing countries?Srivastava, A. et al. | 2003
- 397
-
Standardization of FVIII & FIX assaysBarrowcliffe, T. W. et al. | 2003
- 403
-
Delivery of treatment for haemophilia| 2003
- 405
-
The management of inhibitors in haemophilia A: introduction and systematic review of current practicePaisley, S. / Wight, J. / Currie, E. / Knight, C. et al. | 2003
- 418
-
The epidemiology of inhibitors in haemophilia A: a systematic reviewWight, J. / Paisley, S. et al. | 2003
- 436
-
Immune tolerance induction in patients with haemophilia A with inhibitors: a systematic reviewWight, J. / Paisley, S. / Knight, C. et al. | 2003
- 464
-
Control of bleeding in patients with haemophilia A with inhibitors: a systematic reviewLloyd Jones, M. / Wight, J. / Paisley, S. / Knight, C. et al. | 2003
- 521
-
Economic modelling of different treatment strategies for haemophilia A with high‐responding inhibitorsKnight, C. / Paisley, S. / Wight, J. / Jones, M. L. et al. | 2003
- 541
-
Immunization of patients with bleeding disordersMakris, M. / Conlon, C. P. / Watson, H. G. et al. | 2003
- 547
-
Haemophilic arthropathy in haemophilia patients with inhibitors: new perspectivesRodriguez‐Merchan, E. C. et al. | 2003
- 549
-
Practice patterns in haemophilia A therapy – a survey of treatment centres in the United StatesButler, Regina B. / McClure, Wilma / Wulff, Karen et al. | 2003
- 555
-
On‐demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcomeSteen Carlsson, K. / Höjgård, S. / Glomstein, A. / Lethagen, S. / Schulman, S. / Tengborn, L. / Lindgren, A. / Berntorp, E. / Lindgren, B. et al. | 2003
- 567
-
Impact of inhibitor epitope profile on the neutralizing effect against plasma‐derived and recombinant factor VIII concentrates in vitroAstermark, J. / Voorberg, J. / Lenk, H. / DiMichele, D. / Shapiro, A. / Tjönnfjord, G. / Berntorp, E. et al. | 2003
- 573
-
Intracranial haemorrhage among a population of haemophilic patients in BrazilAntunes, S. V. / Vicari, P. / Cavalheiro, S. / Bordin, J. O. et al. | 2003
- 578
-
Central venous catheter‐related thrombosis presenting as superior vena cava syndrome in a haemophilic patient with inhibitorsCarcao, M. D. / Connolly, B. L. / Chait, P. / Stain, A. M. / Acebes, M. / Massicotte, P. / Blanchette, V. S. et al. | 2003
- 584
-
Exclusion of mosaicism in Spanish haemophilia A families with inversion of intron 22Tizzano, E. F. / Cornet, M. / Domènech, M. / Baiget, M. et al. | 2003
- 588
-
Surveillance of infectious complications associated with central venous access devices in children with haemophiliaTarantino, M. D. / Lail, A. / Donfield, S. M. / Lynn, H. / Peddle, L. / Hunsberger, S. / Shapiro, A. D. et al. | 2003
- 593
-
Is attention deficit hyperactivity disorder over‐represented among HIV‐seronegative boys with haemophilia? Preliminary results from our centreWodrich, D. L. / Recht, M. / Gradowski, M. / Wagner, L. et al. | 2003
- 598
-
HCV recovery from peripheral blood mononuclear cell culture supernatants derived from HCV–HIV co‐infected haemophilic patients with undetectable HCV viraemiaBaré, P. / Massud, I. / Belmonte, L. / Corti, M. / Villafañe, M. / Pérez Bianco, R. / De Tezanos‐pinto, M. / De Bracco, M. M. E. / Ruibal‐Ares, B. et al. | 2003
- 605
-
Progression of HIV infection and mortality by hepatitis C infection in patients with haemophilia over 20 yearsQuintana, M. / Del Amo, J. / Barrasa, A. / Pérez‐Hoyos, S. / Ferreros, I. / Hernández, F. / Villar, A. / Jiménez, V. / Bolúmar, F. et al. | 2003
- 613
-
Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infectionDiMichele, D. M. / Mirani, G. / Wilfredo Canchis, P. / Trost, D. W. / Talal, A. H. et al. | 2003
- 619
-
Psychological aspects and coping in haemophilic patients: a case–control studyCanclini, M. / Saviolo‐Negrin, N. / Zanon, E. / Bertoletti, R. / Girolami, A. / Pagnan, A. et al. | 2003
- 625
-
Elective orthopaedic surgery for inhibitor patientsRodriguez‐Merchan, E. C. / Wiedel, J. D. / Wallny, T. / Hvid, I. / Berntorp, E. / Rivard, G‐E / Goddard, N. J. / Querol, F. / Caviglia, H. et al. | 2003
- 632
-
Radionuclide synovectomy and chronic haemophilic synovitis in Asians: a retrospective studyChew, E. M. D. / Tien, S. L. / Sundram, F. X. / Ho, Y. K. L. / Howe, T. S. et al. | 2003
- 638
-
An acquired factor VIII inhibitor in association with a myeloproliferative/myelodysplastic disorder presenting with severe subcutaneous haemorrhageBiss, T. / Crossman, L. / Neilly, I. / Hanley, J. et al. | 2003
- 642
-
Acquired factor VIII inhibitor in a non‐haemophilic boyKlukowska, A. / Łaguna, P. / Obitko‐Płudowska, A. / Niedzielska, K. / Malinowska, I. / Rokicka‐Milewska, R. et al. | 2003
- 646
-
Type I coagulation factor V deficiency caused by compound heterozygous mutation of F5 geneFu, Q. / Wu, W. / Ding, Q. / Hu, Y. / Wang, X. / Wang, H. / Wang, Z. et al. | 2003
- 650
-
Successful use of B‐domain deleted factor VIII for resection of pituitary adenoma in a paediatric patient with severe haemophilia AHanrahan, J. / McKinnell, J. / Storrs, B. / Jones, J. E. / Schwartz, M. / Townsend, K. / Halona, M. / Mathew, P. et al. | 2003
- 654
-
ELISA for factor VIII antibodies: does it detect antibodies much before the conventional Bethesda assay?Shetty, S. / Ghosh, K. / Mohanty, D. et al. | 2003
- 655
-
The seroprevalance of viral infections and their effects on immune system in turkish haemophiliac patientsTurken, O. / Solmazgul, E. / Sipahi, S. / Ozturk, A. / Ozturkeri, Hakan et al. | 2003
- 657
-
Prevalence of Kaposi's sarcoma‐associated herpesvirus infection in haemophilic patientsTheodossiades, G. / Arvanitakis, L. / Tsevrenis, V. / Nomikou, E. / Zografidis, A. / Bourboulia, D. / Kontopoulou‐Griva, I. et al. | 2003
- 660
-
Inherited haemostatic disorders in idiopathic menorrhagia: Do the special interest of a hemostatic laboratory make a difference?Ghosh, K / Nair, S / Kulkarni, B / Khare, A / Trasi, S / Shetty, S / Mohanty, D et al. | 2003
- 663
-
The World Federation of Hemophilia: 40 years of improving haemophilia care worldwideJones, Peter / Robillard, Line et al. | 2003
- 670
-
Why is primary prophylaxis underutilized in the United States?Shapiro, A. D. et al. | 2003
- 673
-
The dental management of adult patients with haemophilia and other congenital bleeding disordersBrewer, A. K. / Roebuck, E. M. / Donachie, M. / Hazard, A. / Gordon, K. / Fung, D. / Clarkson, J. et al. | 2003
- 678
-
Health‐related quality of life assessment in adult haemophilia patients: a systematic review and evaluation of instrumentsSzende, A. / Schramm, W. / Flood, E. / Larson, P. / Gorina, E. / Rentz, A. M. / Snyder, L. et al. | 2003
- 688
-
Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate‐P®): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapyGill, J. Cox / Ewenstein, B. M. / Thompson, A. R. / Mueller‐Velten, G. / Schwartz, B. A. / for the Humate‐P<sup>®</sup> Study Group et al. | 2003
- 696
-
Retrospective analysis of 1312 patients with haemophilia and related disorders in a single Chinese instituteZhang, L. / Li, H. / Zhao, H. / Zhang, X. / Ji, L. / Yang, R. et al. | 2003
- 703
-
Renal disease among males with haemophiliaKulkarni, R. / Soucie, J. Michael / Evatt, B. / the Hemophilia Surveillance System Project Investigators et al. | 2003
- 711
-
Immunoadsorption for coagulation factor inhibitors: a retrospective critical appraisal of 10 consecutive cases from a single institutionRivard, G. E. / St Louis, J. / Lacroix, S. / Champagne, M. / Rock, G. et al. | 2003
- 717
-
Germ‐line origin of intron 1 inversion in two haemophilia A familiesAcquila, M. / Pasino, M. / Santoro, C. / Lanza, T. / Molinari, A. C. / Bottini, F. / Bicocchi, M. P. et al. | 2003
- 721
-
Iliopsoas haemorrhage in patients with bleeding disorders – experience from one centreAshrani, A. A. / Osip, J. / Christie, B. / Key, N. S. et al. | 2003
- 727
-
Molecular challenges and viral diseasesBrown, Simon A / Aledort, Louis M / Lee, Christine A et al. | 2003
- 738
-
Concurrent total hip and knee replacements in a patient with haemophilia with inhibitors using recombinant factor VIIa by continuous infusionTagariello, G. / Bisson, R. / Radossi, P. / Petris, U. / Zanardo, G. / De Biasi, E. / Risato, R. / Polese, F. / Davoli, P. G. et al. | 2003
- 741
-
Successful treatment of acquired haemophilia with prednisolone therapyAli, R. / Özçelik, T. / Özkalemkaş, F. / Özkocaman, V. / Ozan, Ü. / Yalçin, M. / Saricaoğlu, H. / Tunali, A. et al. | 2003
- 744
-
Meta‐analysis on the effectiveness of B‐domain deleted factor VIII for prophylaxisVan Der Bom, J. G. / Fischer, K. / Van Den Berg, H. M. et al. | 2003
- 745
-
Comparative study of full‐length and B‐domain deleted factor VIII concentratesBrown, S. A. / Yee, T. T. / Griffioen, A. / Lee, C. A. et al. | 2003
- 746
-
Controversial use of meta‐analysis for factor VIII pharmacokinetic dataLee, M. L. / Morfini, M et al. | 2003
- 748
-
Meta‐analysis of observational studies of full‐length and B‐domain‐deleted factor VIII for prophylaxis – a standard statistical approachGruppo, R. A. / Brown, D. / Wilkes, M. M. / Navickis, R. J. et al. | 2003
- 751
-
Keyword index| 2003
- 753
-
Author index| 2003